Abstract
A comparison between regular and high doses of Trifluoperazine (TR-60 mg and TR-600 mg) was made on 26 newly admitted schizophrenics with acute psychotic symptoms. Eleven received the regular dose of the drug (TR-60 mg) and 15 received the high dose (TR-600 mg). Treatment's duration was 6 weeks. Psychiatric evaluations were done by means of Patient Personal Data Inventory, Brief Psychiatric Rating Scale, Impatient Multidimensional Psychiatric Scale, Digit Symbol Test, Continuous Scanning, Side Effects, and Extrapyramidal Status. Almost all patients from both groups generally improved from the beginning to the end of the study with TR-, but the results provide no support for the contention that very high doses of TR-are more effective than regular doses.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Collomb, J.: The value of Trifluoperazine in high doses in psychiatric hospital practice. Medical Thesis, 1969
Cornil, J., Kugener, J.: Clinical study of Trifluoperazine. Gaz. med. Fr. 22, 2–8 (1970)
Wilkin, M. O.: Preliminary results of Terfluzine in high doses in psychiatry. Bordeaux Med. 12, 2779–2781 (1969)
Neurological syndrome associated with antipsychotic drug use. Arch. gen. Psychiat. 28, 463–472 (1973)
Author information
Authors and Affiliations
Additional information
On sabbatical year, from the National Institute of Mental Health, Rockville, Maryland.
Rights and permissions
About this article
Cite this article
Wijsenbeek, H., Steiner, M. & Goldberg, S.C. Trifluoperazine: A comparison between regular and high doses. Psychopharmacologia 36, 147–150 (1974). https://doi.org/10.1007/BF00421786
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00421786